Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel Saffran

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|August 1, 2024
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted TherapyGeorge Mellgard, Nathaniel Saffran, Zakaria Chakrani, et al.
American Journal of Clinical Oncology|February 12, 2024
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted TherapyZakaria Chakrani, George Mellgard, Nathaniel Saffran, et al.
Clinical Genitourinary Cancer|October 22, 2024
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)Zakaria Chakrani, Mann Patel, George Mellgard, et al.
Frontiers in Genetics|February 3, 2022
Emerging Role of Exosomal Long Non-coding RNAs in Spaceflight-Associated Risks in AstronautsMalik Bisserier, Nathaniel Saffran, Agnieszka Brojakowska, et al.
Frontiers in Cardiovascular Medicine|July 5, 2022
Astronauts Plasma-Derived Exosomes Induced Aberrant EZH2-Mediated H3K27me3 Epigenetic Regulation of the Vitamin D ReceptorMalik Bisserier, Agnieszka Brojakowska, Nathaniel Saffran, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|August 1, 2024
Performance Status and End-of-Life Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Androgen Receptor Targeted TherapyGeorge Mellgard, Nathaniel Saffran, Zakaria Chakrani, et al.
American Journal of Clinical Oncology|February 12, 2024
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted TherapyZakaria Chakrani, George Mellgard, Nathaniel Saffran, et al.
Clinical Genitourinary Cancer|October 22, 2024
The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART)Zakaria Chakrani, Mann Patel, George Mellgard, et al.
Frontiers in Genetics|February 3, 2022
Emerging Role of Exosomal Long Non-coding RNAs in Spaceflight-Associated Risks in AstronautsMalik Bisserier, Nathaniel Saffran, Agnieszka Brojakowska, et al.
Frontiers in Cardiovascular Medicine|July 5, 2022
Astronauts Plasma-Derived Exosomes Induced Aberrant EZH2-Mediated H3K27me3 Epigenetic Regulation of the Vitamin D ReceptorMalik Bisserier, Agnieszka Brojakowska, Nathaniel Saffran, et al.
Pageof 1